Drug Shortage Report for MYXREDLIN
| Report ID | 272638 |
| Drug Identification Number | 02529602 |
| Brand name | MYXREDLIN |
| Common or Proper name | INSULIN HUMAN IN 0.9% SODIUM CHLORIDE INJECTION |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | INSULIN |
| Strength(s) | 1UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 100mL (Product Code CA2G3322) |
| ATC code | A10AB |
| ATC description | INSULINS AND ANALOGUES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-12-05 |
| Actual start date | 2025-12-05 |
| Estimated end date | 2026-02-15 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-12-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-12-05 | French | Compare |
| v3 | 2025-12-05 | English | Compare |
| v2 | 2025-11-27 | French | Compare |
| v1 | 2025-11-27 | English | Compare |
Showing 1 to 4 of 4